Sepse tardia em Unidade de Tratamento Intensivo Neonatal

Justificativa e Objetivos: É essencial conhecer os microrganismos presentes em hemoculturas de pacientes pediátricos internados para uma melhor escolha da terapêutica antibiótica. Dessa forma, este trabalho tem como objetivo verificar a associação entre parâmetros clínicos e epidemiológicos com o desenvolvimento de sepse neonatal tardia em pacientes internados em um serviço de pediatria de um hospital do sul do Brasil. Métodos: Estudo transversal, descritivo, retrospectivo e qualiquantitativo que utilizou dados secundários oriundos dos prontuários de pacientes que apresentaram critérios clínicos para sepse neonatal, internados na Unidade de Tratamento Intensivo Neonatal (UTIN) do Hospital Santa Cruz. Resultados: Dos 588 pacientes internados na UTIN do Hospital Santa Cruz no período de 01/01/2013 a 31/12/2015, 123 recém-nascidos (RNs) preencheram os critérios para sepse neonatal tardia. Destes, 59 (47,97%) apresentaram hemocultura positiva, o que foi mais frequente em RNs prematuros (39,84%) e de baixo peso (43,90%), embora não tenha havido associação estatisticamente significativa entre estes fatores e hemocultura positiva. Dentre os possíveis fatores de risco para o desenvolvimento de sepse neonatal, o uso de ventilação mecânica (p=0,005), realização de cirurgia (p=0,019) e permanência no hospital por mais de um mês (p=0,001) apresentaram associação estatística com hemocultura positiva. Os microrganismos presentes em maior frequência nas hemoculturas foram os estafilococos coagulasenegativa (S. epidermidis, S. saprophyticus e S. haemolyticus), encontrados em 35,71% das hemoculturas analisadas. Conclusão: O estudo evidenciou maior prevalência de sepse neonatal tardia em RNs prematuros e de baixo peso, que necessitaram de maiores cuidados e foram submetidos a maior manipulação durante a permanência na UTIN. Procedimentos invasivos e longa permanência hospitalar se associaram significativamente com hemocultura positiva, corroborando com o descrito na literatura

Sepse tardia em Unidade de Tratamento Intensivo Neonatal

Background and Objectives: It is essential recognize the microorganisms present in hemoculture in pediatric patients internees for a better choice of antibiotic therapy. In this way, this work aims assess the association between clinical and epidemiological parameters with the onset of late neonatal sepsis in hospitalized patients, in a pediatric service of the south of Brazil. Methods: A cross-sectional, descriptive, retrospective, qualitative and quantitative study that used secondary data from the files of patients which presented clinical criteria indicating neonatal sepsis, that were hospitalized in the Neonatal Intensive Care Unit (NICU) at Hospital Santa Cruz. Results: Out of the 588 patients hospitalized in the NICU from 01/01/2013 to 12/31/2015, 123 newborns (NBs) filled the criteria for late neonatal sepsis. Out of these, 59 (47,97%) presented with positive hemoculture, which was more frequent in preterms NBs (39,84%) and low birth weight (43,90%), although there was no statistically significant associantion between these factors and positive hemoculture. From the possible risk factors for the onset of neonatal sepsis, mechanical ventilation (p=0,005), having performed surgery (p=0,019) and in-hospital stay longer than a month (p=0,001) showed statistic association with positive hemoculture. The microrganisms that were the most frequent were the coagulasenegative staphylococci (S. epidermidis, S. saprophyticu and S. haemolyticus), found in 37,71% of the analyzed hemocultures. Conclusion: This study showed higher prevalence of neonatal sepsis on premature NBs and on low-weight NBs that required higher care and suffered invasive procedures during the stay in the NICU. Invasive procedures and long hospital stay were significantly associated with positive hemoculture, corroborating with tah described in the literature.Justificación y Objetivos: Es esencial conocer los microorganismos presentes em las hemoculturas de pacientes pediátricos internados para una mejor elección de la terapia antibiótica. De esta forma, este trabajo tiene como objetivo verificar la asociación entre parámetros clínicos y epidemiológicos con el desarrollo de sepsis neonatal tardía en pacientes internados en un servicio de pediatría de un hospital del sur de Brasil. Métodos: Estudio transversal, descriptivo, retrospectivo y cualiquantitativo que utilizó datos secundarios oriundos de los prontuarios de pacientes que presentaron criterios clínicos para sepsis neonatal, internados en la Unidad de Tratamiento Intensivo Neonatal (UTIN) del Hospital Santa Cruz. Resultados: De los 588 pacientes internados en la UTIN del Hospital Santa Cruz en el período de 01/01/2013 a 31/12/2015, 123 recién nacidos (RNs) cumplieron los criterios para sepsis neonatal tardía. De estos, 59 (47,97%) presentaron hemocultura positiva, lo que fue más frecuente en RNs prematuros (39,84%) y de bajo peso (43,90%), aunque no hubo asociación estadísticamente significativa entre estos factores y hemocultura positiva. Entre los posibles factores de riesgo para el desarrollo de sepsis neonatal, el uso de ventilación mecánica (p=0,005), realización de cirugía (p=0,019) y permanencia en el hospital por más de un mês (p=0,001) presentaron asociación estadística con hemocultura positiva. Los microorganismos presentes en mayor frecuencia en los hemocultivos fueron los estafilococos coagulasa-negativos (S. epidermidis, S. saprophyticus y S. haemolyticus), encontrados en el 35,71% de los hemocultivos analizados. Conclusión: El estudio evidenció mayor prevalencia de sepsis neonatal tardía en RNs prematuros y de bajo peso, que requirieron mayores cuidados y fueron sometidos a mayor manipulación durante la permanencia en la UTIN. Los procedimientos invasivos y larga permanencia hospitalaria se asociaron significativamente con hemocultura positiva, corroborando con lo descrito en la literatura.Justificativa e Objetivos: É essencial conhecer os microrganismos presentes em hemoculturas de pacientes pediátricos internados para uma melhor escolha da terapêutica antibiótica. Dessa forma, este trabalho tem como objetivo verificar a associação entre parâmetros clínicos e epidemiológicos com o desenvolvimento de sepse neonatal tardia em pacientes internados em um serviço de pediatria de um hospital do sul do Brasil. Métodos: Estudo transversal, descritivo, retrospectivo e qualiquantitativo que utilizou dados secundários oriundos dos prontuários de pacientes que apresentaram critérios clínicos para sepse neonatal, internados na Unidade de Tratamento Intensivo Neonatal (UTIN) do Hospital Santa Cruz. Resultados: Dos 588 pacientes internados na UTIN do Hospital Santa Cruz no período de 01/01/2013 a 31/12/2015, 123 recém-nascidos (RNs) preencheram os critérios para sepse neonatal tardia. Destes, 59 (47,97%) apresentaram hemocultura positiva, o que foi mais frequente em RNs prematuros (39,84%) e de baixo peso (43,90%), embora não tenha havido associação estatisticamente significativa entre estes fatores e hemocultura positiva. Dentre os possíveis fatores de risco para o desenvolvimento de sepse neonatal, o uso de ventilação mecânica (p=0,005), realização de cirurgia (p=0,019) e permanência no hospital por mais de um mês (p=0,001) apresentaram associação estatística com hemocultura positiva. Os microrganismos presentes em maior frequência nas hemoculturas foram os estafilococos coagulase negativa (S. epidermidis, S. saprophyticus e S. haemolyticus), encontrados em 35,71% das hemoculturas analisadas. Conclusão: O estudo evidenciou maior prevalência de sepse neonatal tardia em RNs prematuros e de baixo peso, que necessitaram de maiores cuidados e foram submetidos a maior manipulação durante a permanência na UTIN. Procedimentos invasivos e longa permanência hospitalar se associaram significativamente com hemocultura positiva, corroborando com o descrito na literatura

Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to <90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], >300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of <15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P<0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P<0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years

Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, GALACTIC‐HF: baseline characteristics and comparison with contemporary clinical trials

Aims: The safety and efficacy of the novel selective cardiac myosin activator, omecamtiv mecarbil, in patients with heart failure with reduced ejection fraction (HFrEF) is tested in the Global Approach to Lowering Adverse Cardiac outcomes Through Improving Contractility in Heart Failure (GALACTIC‐HF) trial. Here we describe the baseline characteristics of participants in GALACTIC‐HF and how these compare with other contemporary trials. Methods and Results: Adults with established HFrEF, New York Heart Association functional class (NYHA) ≥ II, EF ≤35%, elevated natriuretic peptides and either current hospitalization for HF or history of hospitalization/ emergency department visit for HF within a year were randomized to either placebo or omecamtiv mecarbil (pharmacokinetic‐guided dosing: 25, 37.5 or 50 mg bid). 8256 patients [male (79%), non‐white (22%), mean age 65 years] were enrolled with a mean EF 27%, ischemic etiology in 54%, NYHA II 53% and III/IV 47%, and median NT‐proBNP 1971 pg/mL. HF therapies at baseline were among the most effectively employed in contemporary HF trials. GALACTIC‐HF randomized patients representative of recent HF registries and trials with substantial numbers of patients also having characteristics understudied in previous trials including more from North America (n = 1386), enrolled as inpatients (n = 2084), systolic blood pressure < 100 mmHg (n = 1127), estimated glomerular filtration rate < 30 mL/min/1.73 m2 (n = 528), and treated with sacubitril‐valsartan at baseline (n = 1594). Conclusions: GALACTIC‐HF enrolled a well‐treated, high‐risk population from both inpatient and outpatient settings, which will provide a definitive evaluation of the efficacy and safety of this novel therapy, as well as informing its potential future implementation

Evaluation of the effect of BCG neonatal vaccination on the reaction of the tuberculin test in the first two years of life

Submitted by PPG Pediatria e Sa?de da Crian?a ([email protected]) on 2018-02-16T18:56:46Z No. of bitstreams: 1 Tese Doutorado - Tatiana Kurtz -FINAL (1).pdf: 3145488 bytes, checksum: 8d9c7ca2d5630d7d9e3c1060cce48762 (MD5)Approved for entry into archive by Caroline Xavier ([email protected]) on 2018-02-22T16:58:20Z (GMT) No. of bitstreams: 1 Tese Doutorado - Tatiana Kurtz -FINAL (1).pdf: 3145488 bytes, checksum: 8d9c7ca2d5630d7d9e3c1060cce48762 (MD5)Made available in DSpace on 2018-02-22T17:05:19Z (GMT). No. of bitstreams: 1 Tese Doutorado - Tatiana Kurtz -FINAL (1).pdf: 3145488 bytes, checksum: 8d9c7ca2d5630d7d9e3c1060cce48762 (MD5) Previous issue date: 2017-08-31Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior - CAPESIntroduction and Objectives: Tuberculosis (TB) is a complex infectious disease that can occur in any age group. When the host comes in contact with Mycobacterium tuberculosis (MTB) the immune response of the organism may be sufficient to prevent the disease, resulting in total destruction of the bacteria or establishment of latency, termed latent tuberculosis (TBL). Due to the difficulty in demonstrating MTB in the clinical specimens of the child, the diagnosis of TB disease is based on the clinical, epidemiological and radiological bases associated with the interpretation of the cutaneous tuberculin (TT) test. In this context, Mycobacterium tuberculosis infection, mostly latent, represents an important reservoir for reactivation of the disease. This contingent is sufficient to continue generating new cases for many decades, even if the chain of transmission is interrupted. Thus, the precise definition of the criteria for diagnosis of latent TB has great relevance and TT is an important tool. The objective of the study is to evaluate the effect of the neonatal BCG vaccine on the tuberculin skin test cutaneous reaction and to define cutoff points to detect tuberculosis in the first two years of life. Methods: A cross-sectional study was carried out in children from the municipality of Santa Cruz do Sul, who met the inclusion criteria of the study: infants up to 2 years of age who received BCG vaccine during the neonatal period. Exclusion criteria were birth weight <2,000 grams, being the mother of HIV positive mother, or mother with persistence of tuberculosis in the perinatal period, or cases where there was evidence of primary immunodeficiency, absence of BCG vaccine scar after 6 months of life, in addition to TB research and TB contact. The children were identified and included through the authorization of the person responsible, explaining the project and accepting the consent term. The project was approved by the Research Ethics Committee of the Santa Cruz Hospital, where patient data were collected and the University of Santa Cruz do Sul (UNISC). The variable under study was the cutaneous induration reaction of the tuberculin test, in the first two years post-vaccination, using different cutoff points. A descriptive analysis of the variables was performed. Numerical variables were represented by mean and standard deviation and categorical variables by means of absolute number and percentage. To describe the data, we used means and standard deviation, or median and interquartile range for the quantitative variables; percentage for qualitative variables. For analysis of the Tuberculin Test, the sample was submitted to the analysis of variance (ANOVA), with significance level of p?0.05. The data analyzed in the SPSS Program 17.0. Results: Potentially eligible participants totaled 808, of which 90 were selected from the inclusion / exclusion criteria. Data collected included demographic characteristics, nutritional indexes, vaccination status and previous exposure to TB. TTs were administered and induration measured after 48-72 hours. The selected ones were of both sexes, with ages varying between 3 and 24 months. Of these, eleven were excluded because they did not attend the reading of the tuberculin test (TT), resulting in a sample of 79 patients. The median age was 9.5 months for boys and 11 months for girls. It was divided into 3 groups according to the age range: between 3-9 months (group 1), 10-18 months (group 2) and 19-24 months of age (group 3). We found that, when comparing the 3 groups, we showed a decrease in the mean response to tuberculin as the age group progresses, presenting statistical significance (p = 0.041). Considering the probable absence of Mycobacterium tuberculosis infection in the sample of patients included in the study, we observed that the tuberculin test with the highest reaction occurs in group 1. From the age of 10 months, no patient shows a reaction to the tuberculin test above 5 mm. The finding shows the decline in the tuberculin reaction curve in the first year of life. A complementary analysis was performed excluding patients who did not present an induration reaction (TT = 0 mm), and 28 patients were excluded from the interpretation. The 51 patients with Test Tuberculin reactor were divided into the same 3 groups according to age group. Between 3-9 months (group 1), 10-18 months (group 2) and 19-24 months of age (group 3), we found that when comparing the 3 groups, again we showed a decrease in the reaction to tuberculin according to age progresses, presenting significance (p = 0.031). We found that there were no adverse effects, described in the literature, in patients who underwent the Tuberculin Test. Conclusions: Based on the data from the study, we demonstrated that the induration reaction occurs in the tuberculin test in the first 12 months of age in previously healthy and BCG-vaccinated patients in the neonatal period. Therefore our results suggest that the cutoff point could be modified from 10mm to 5mm of induration after 12 months of age, improving the specificity of the TT diagnostic test to identify cases of TB infection. This reevaluation of the lowest cutoff point in the first two years of life may prevent inappropriate management in patients with tuberculosis.Introdu??o e Objetivos: A tuberculose (TB) ? uma doen?a infecciosa complexa, podendo ocorrer em qualquer faixa et?ria. Quando o hospedeiro entra em contato com o Mycobacterium tuberculosis (MTB) a resposta imunit?ria do organismo pode ser suficiente para evitar a doen?a, ocorrendo destrui??o total das bact?rias ou estabelecimento de um estado de lat?ncia, denominado de tuberculose latente (TBL). Devido ? dificuldade em demonstrar MTB nos esp?cimes cl?nicos da crian?a, o diagn?stico da TB doen?a ? fundamentado em bases cl?nicas, epidemiol?gicas e radiol?gicas associados ? interpreta??o do teste tubercul?nico (TT) cut?neo. Neste contexto, verifica-se que a infec??o pelo Mycobacterium tuberculosis, na sua maioria forma latente, representa um importante reservat?rio de reativa??o da doen?a. Este contingente ? suficiente para continuar gerando novos casos por muitas d?cadas, mesmo que a cadeia de transmiss?o seja interrompida. Dessa forma, a defini??o precisa dos crit?rios para diagn?stico de TB latente tem grande relev?ncia e o TT ? uma importante ferramenta. O objetivo do estudo ? avaliar o efeito da vacina BCG neonatal na rea??o de endura??o cut?nea do Teste Tubercul?nico e definir pontos de corte para detectar tuberculose nos dois primeiros anos de vida. M?todos: Estudo transversal, em crian?as do munic?pio de Santa Cruz do Sul, que se adequaram aos crit?rios de inclus?o do estudo: lactentes at? 2 anos de idade que receberam vacina BCG durante o per?odo neonatal. Crit?rios de exclus?o foram: peso ao nascimento <2,000 gramas, ser filho de m?e HIV positiva, ou m?e com vig?ncia de tuberculose no per?odo perinatal, ou ainda os casos em que houve evid?ncia de imunodefici?ncia prim?ria, aus?ncia de cicatriz vacinal de BCG ap?s 6 meses de vida, al?m de investiga??o de TB e contato de TB. As crian?as foram identificadas e inclu?das atrav?s de autoriza??o do respons?vel, mediante explica??o do projeto e aceita??o do termo de consentimento. O projeto foi aprovado pela Comiss?o de ?tica em Pesquisa do Hospital Santa Cruz, onde foi realizada a coleta de dados dos pacientes e Universidade de Santa Cruz do Sul (UNISC). A vari?vel em estudo foi a rea??o de endura??o cut?nea do teste tubercul?nico, nos dois primeiros anos p?s-vacina??o, utilizando diferentes pontos de corte. Realizada uma an?lise descritiva das vari?veis. As vari?veis num?ricas foram representadas por meio de m?dia e desvio padr?o e as categ?ricas por meio de n?mero absoluto e porcentagem. Para descri??o dos dados, foram utilizados m?dias e desvio padr?o, ou mediana e intervalo interquartil para as vari?veis quantitativas; porcentagem para as vari?veis qualitativas. Para an?lise do Teste Tubercul?nico a amostra foi submetida ao teste de an?lise de vari?ncia (ANOVA), com n?vel de signific?ncia de p?0,05. Os dados analisados no Programa SPSS 17.0. Resultados: Os participantes potencialmente eleg?veis totalizaram 808, desses 90 foram selecionados a partir dos crit?rios de inclus?o/exclus?o. Dados coletados inclu?ram caracter?sticas demogr?ficas, ?ndices nutricionais, estado de vacina??o e exposi??o pr?via ? TB. TTs foram administrados e a endura??o medida ap?s 48-72 horas. Os selecionados foram de ambos os sexos, com idade variando entre 3 e 24 meses. Destes, onze foram exclu?das, pois n?o compareceram a leitura do teste tubercul?nico (TT), resultando em amostra final de 79 pacientes. A mediana das idades foi de 9,5 meses, entre os meninos, e 11 meses entre as meninas. Realizada divis?o em 3 grupos conforme faixa et?ria: entre 3-9 meses (grupo 1), 10-18 meses (grupo 2) e 19-24 meses de idade (grupo 3). Constatamos que, quando comparados os 3 grupos, evidenciamos queda na m?dia de rea??o ? tuberculina conforme a faixa et?ria progride, apresentando signific?ncia estat?stica (p= 0.041). Considerando a prov?vel aus?ncia de infec??o por Mycobacterium tuberculosis na amostra de pacientes inclu?dos no estudo, observamos que o teste tubercul?nico com rea??o mais elevada ocorre no grupo 1. A partir dos 10 meses de idade nenhum paciente demonstra rea??o ao teste tubercul?nico acima de 5 mm. O achado evidencia o decl?nio na curva de rea??o ? tuberculina j? no primeiro ano de vida. Realizada an?lise complementar excluindo os pacientes que n?o apresentaram rea??o de endura??o (TT= 0 mm), sendo exclu?dos da interpreta??o 28 pacientes. Os 51 pacientes com Teste Tubercul?nico reator foram divididos nos mesmos 3 grupos conforme faixa et?ria. Entre 3-9 meses (grupo 1), 10-18 meses (grupo 2) e 19-24 meses de idade (grupo 3), onde constatamos que quando comparados os 3 grupos, novamente evidenciamos queda na rea??o ? tuberculina conforme a faixa et?ria progride, apresentando signific?ncia (p= 0.031). Constatamos que n?o ocorreram efeitos adversos, descritos em literatura, nos pacientes que se submeteram a aplica??o do Teste Tubercul?nico. Conclus?es: A partir dos dados do estudo demonstramos que ocorre queda da rea??o de endura??o no teste tubercul?nico nos primeiros 12 meses de idade em pacientes previamente h?gidos e vacinados com BCG no per?odo neonatal. Portanto nossos resultados sugerem que o ponto de corte poderia ser modificado de 10mm para 5mm de endura??o ap?s os 12 meses de idade, melhorando a especificidade do teste diagn?stico TT para identifica??o dos casos de TB infec??o. Esta reavalia??o do ponto de corte menor nos dois primeiros anos de vida pode evitar manejos inadequados nos pacientes com contato com tuberculose